Under construction – not a live service
Sign in
Not yet taking people in FinlandNo phase

Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients

Key facts

Where
Tampere, FinlandSee the site

Where in Finland

  • Tampere University, Faculty of Medicine and Health TechnologyTampere, FinlandContact: Kalle KurppaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Tampere University Hospital
Trial code
NCT07366151
Record updated
26 January 2026
Original description
The primary aim of this project is to investigate how active screening and the timing of diagnosis affect the long-term health outcomes of patients with celiac disease. Additionally, the study seeks to clarify the natural course of so-called potential celiac disease. A key focus is also placed on assessing adherence to a gluten-free diet among screen-detected and, if initiated, potential celiac disease patients, their satisfaction with the diagnosis, and the diet's impact on general health and quality of life.Read full original descriptionShow less

The Impact of Active Screening on the Long-term Health of Celiac Disease Patients and the Natural Course of Potential Untreated or Treated Celiac Disease

The primary aim of this project is to investigate how active screening and the timing of diagnosis affect the long-term health outcomes of patients with celiac disease. Additionally, the study seeks to clarify the natural course of so-called potential celiac disease. A key focus is also placed on assessing adherence to a gluten-free diet among screen-detected and, if initiated, potential celiac disease patients, their satisfaction with the diagnosis, and the diet's impact on general health and quality of life.

Inclusion: Finnish citizenship and current residence in Finland.

Exclusion: Age <18 years.

ClinicalTrials.gov NCT07366151